July 10, 2025 — Fujifilm Healthcare Americas Corp. has launched several advanced automated functions for its FDR Visionary Suite digital radiography room. Optimized to support high-volume imaging in hospital radiology departments and imaging centers, the automation features are designed to enhance workflow and improve the patient and technologist experience for a wide range of general radiology exams.

June 9, 2025 — bioAffinity Technologies, Inc., a biotechnology company addressing the need for noninvasive, accurate tests for the detection of early-stage cancer, has released a new case study of a complex clinical case in which CyPath Lung identified Stage 1A adenocarcinoma lung cancer in a patient whose PET imaging and risk model probability indicated a low risk of malignancy.

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ArteraAI Prostate, an AI precision medicine tool intended to assist clinicians with risk-based decisions for patients with localized prostate cancer.

July 9, 2025 — The American Society for Radiation Oncology (ASTRO) selected 43 members to receive the ASTRO Fellow (FASTRO) designation this year. This prestigious honor recognizes ASTRO members’ outstanding achievements and contributions to the Society, cancer research, education, patient care and the specialty. The new Fellows will be recognized at ASTRO’s 67th Annual Meeting in San Francisco in September.

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior director of clinical operations. These additions to the leadership team significantly enhance the company’s medical and clinical capabilities as QTI expands its clinical studies as well as the development of AI-driven lesion classification and second-read decision support tools alongside the commercialization of its FDA-cleared QTI Breast Acoustic CT™ scanner.

July 2, 2025 — Lunit, a provider of AI for cancer diagnostics and therapeutics, has announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions. In conjunction with their recent acquisition of Volpara, a Microsoft Industry Health Certified Partner, this collaboration will give health professionals globally access to tools that will assist in the detection of cancer.

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has launched Mammogram+ and Mammogram+ Heart, two new AI-enhanced mammogram services aimed at improving early detection and advancing preventative care.

July 8, 2025 — Mendaera, Inc., a healthcare technology company focused on developing robotics that can be deployed universally in medicine, recently announced  it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its handheld robotic system, Focalist. The novel system is designed to simplify and enhance the precision of ultrasound-guided needle placement — a technically demanding procedure performed across many specialties and care settings. The company is commencing a limited launch with select medical institutions.

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University, one of Florida’s largest private, non-profit university.

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise1 MR’s latest deep learning reconstruction software, marking a major milestone in the journey toward autonomous, personalized MRI. SmartSpeed Precise is the industry's first integrated dual AI solution, delivering up to 3x faster scanning2 and up to 80% sharper images3 —  in one click. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now